United Therapeutics Financials

Values in thousands	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Revenue	$798,600	$794,400	$735,900	$748,900
Gross Profit	711,000	701,900	660,000	665,800
EBITDA	436,800	382,800	424,100	417,800
EBIT	415,700	417,400	404,400	398,700
Net Income	309,500	322,200	301,300	309,100
Net Change In Cash	798,600	794,400	735,900	748,900
Free Cash Flow	129,500	386,300	254,500	300,700
Cash	1,593,100	1,899,900	1,697,200	1,553,900
Basic Shares	48,300	48,600	48,700	48,400

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,877,400	$2,327,500	$1,936,300	$1,685,500
Gross Profit	2,567,700	2,070,000	1,789,600	1,563,000
EBITDA	1,654,400	1,386,800	1,040,300	736,800
EBIT	1,581,900	1,333,600	989,000	686,900
Net Income	1,195,100	984,800	727,300	475,800
Net Change In Cash	2,877,400	2,327,500	1,936,300	1,685,500
Cost of Revenue			66,400	156,100
Free Cash Flow	1,080,600	747,600	663,700	477,400
Cash	1,697,200	1,207,700	961,200	894,800
Basic Shares	48,500	49,700	48,500	47,300